WILEX AG announces results of Phase III ARISER study with RENCAREX ® in clear cell renal cell carcinoma

< p > Trial did not meet its primary endpoint of median disease-free survival (DFS) < /p > < p > 10/17/2012 < /p >
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news